Towards the use of nanoparticles in cancer therapy and imaging

Drug News and Perspectives

Volumn 20, Issue 4, 2007, Pages 213-220

  Pauwels, Ernest K J ^a,b   Erba, Paola ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOTUBE; FERUMOXSIL; FLUORODEOXYGLUCOSE F 18; LANTHANIDE; LIPOCORTIN 5; LIPOSOME; MEMBRANE ANTIGEN; NANOCRYSTAL; NANOPARTICLE; PACLITAXEL; SUPERPARAMAGNETIC IRON OXIDE; TRACER; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

BLOOD BRAIN BARRIER; BREAST CANCER; CANCER; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG RELEASE; DRUG SOLUBILITY; DRUG TARGETING; GASTROINTESTINAL DISEASE; GENE TARGETING; HUMAN; HYPERTHERMIA; LIVER TUMOR; MICROBUBBLE; NANOTECHNOLOGY; NONHODGKIN LYMPHOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; REVIEW; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; NEOPLASMS; QUANTUM DOTS;

EID: 34547767133     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2007.20.4.1103525     Document Type: Review

References (72)

1. Roco, M.C. Nanotechnology: Converge with modern biology and medicine. Curr Opin Biotechnol 2003, 14: 337-46.
2. Vastag, B. Nanotechnology grows into billion-dollar enterprise. J Natl Cancer Inst 2004, 96: 1566-7.
3. Bashiir, R. BioMEMS: State-of-the-art in detection, opportunities and prospect. Adv Drug Deliv Rev 2004, 56: 1565-86.
4. Chan, W.C. Bionanotechnology progress and advances. Biol Blood Marrow Transplant 2006, 12(1 Suppl. 1): 87-91.
5. Drive, G., Hernandez, R.M., Rodriguez Gascon, A., Dominguez-Gil, A. and Pedraz, J.L. Drug delivery in biotechnology: Present and future. Curr Opin Biotechnol 2003, 14: 659-64.
6. Shenoy, D., Little, S., Langer, R. and Amiji, M. Poly(ethylene oxide)-modified poly-(beta-amino ester)nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: Part 2. In vivo distribution and tumor localization studies. Pharm Res 2005, 22: 2107-14.
7. Sawant, R.M., Hurley, J.P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T.S. and Torchtlin, V.P. "SMART" drug delivery system: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem 2006, 17: 943-9.
8. Oupicky, D., Bisht, H.S., Manickam, D.S. and Zhou, Q.H. Stimulus-controlled delivery of drugs and genes. Expert Opin Drug Deliv 2005, 2: 653-65.
9. Ferrara, N. and Gerber, H.P. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol 2001, 106: 148-56.
10. Wilting, J., Hawighorst, T., Hecht, M., Christ, B. and Papoutsi, M. Development of lymphatic vessels: Tumor lymphangiogenesis and lymphatic invasion. Curr Med Chem 2005, 12: 3043-53.
11. Reddy, L.H. Drug delivery to tumors: Recent strategies. J Pharma Pharmacol 2005, 57: 1231-42.
12. Hilgenbrink, A.R. and Low, P.S. Folate receptor-mediated drug targeting: From therapeutics to diagnostics. J Pharm Sci 2005, 94: 2135-46.
13. Thomas, T.P., Majoras, I.J., Kotlyar, A., Kukowska-Latallo, J.F., Bielinska, A., Myc, A. and Baker, J.R. Jr. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Med Chem 2005, 48: 3729-35.
14. Lin, M.Z., Teitell, M.A. and Schiller, G.J. The evolution of antibodies into versatile tumor-targeting agents. Clin Cancer Res 2005, 11: 129-38.
15. Goldenberg, D.M. and Griffiths, G.L. Radioimmunotherapy of cancer: Arming the missiles. J Nucl Med 1992, 33: 1110-2.
16. Langer, R.S. and Vacanti, J.P. Tissue engineering: The challenges ahead. Sci Am 1999, 280: 86-9.
17. Li, Y. and Luo, D. Multiplexed molecular detection using encoded microparticles and nanoparticles. Expert Rev Mol Diagn 2006, 6: 567-74.
18. Murugan, R. and Ramakrishna, S. Nanofeatured scaffolds for tissue engineering: A review of spinning methodologies. Tissue Eng 2006, 12: 435-47.
19. Moschwitzer, J. and Muller, R.H. New method for effective production of ultrafine drug nanocrystals. J Nanosci Nanotechnol 2006, 6: 3145-53.
20. Muller, R.H. and Keck, C.M. Challengers and solutions for the delivery of drugs-a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 2004, 113: 151-70.
21. Yunhui, W., Loper, A., Landis, E. et al. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of M K-0869: A Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. Int J Pharm 2004, 285: 135-46.
22. Martin, C.R. and Kohli, P. The emerging field of nanotuhe biotechnology. Nat Rev Discov 2003, 2: 29-37.
23. Bianco, A. Carbon nanotubes for the delivery of therapeutic molecules. Expert Opin Drug Deliv2004, 1: 57-65.
24. Harris, J.M. and Chess, R.B. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003, 2: 214-21.
25. Allen, T.M. and Cullis, P.R. Drug delivery system: Entering the mainstream. Science 2004, 303: 1818-22.
26. Gabizon, A.A., Shmeeda, H. and Zallipsky, S. Pros and cons of the liposome platform in cancer drug targeting. J Liposome Res 2006, 16: 175-83.
27. Garcia-Fuentas, M., Torres, D. and Alonso, M.J. New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int J Pharm 2005, 296: 122-32.
28. Sanchez, A., Tobio, M., Gonzales, L., Fabra, A. and Alonso, M.J. Biodegradabile microand nanoparticles as long-term delivery vehicles for interferon-alpha. Eur J Pharm Sci 2003, 18: 221-9.
29. Svenson, S. and Tomalia, D.A. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 2005, 57: 2106-29.
30. Yang, H. and Kao, W.J. Dendrimers for pharmaceuticals and biomedical applications. J Biomat Sci Polym Ed. 2006, 17: 3-19.
31. Manchester, M. and Singh, P. Virus-based nano-particles (VNPs): Platform technologies for diagnostic imaging. Adv Drug Deliv Rev 2006, 58: 1505-22.
32. Jaiswal, J.K., Mattoussi, H., Mauro, J.M. and Simon, S.M. Long-term multiple color imaging of cells using quantum dot bioconjugates. Nat Biotechnol 2003, 21: 47-51.
33. Kim, S., Lim, Y.T., Soltesz, E.G. et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004, 22: 93-7.
34. Cai, W., Shin, D.W., Chen, K. et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 2006, 6: 669-76.
35. Kanematsu, M., Kondo, H., Goshima, S. et al. Imaging liver metastases: Review and update. Eur J Radiol 2006, 58: 217-28.
36. Keller, T.M., Michel, S.C., Frohlich, J., Fink, D., Caduff, R., Marincek, B. and Kubik-Huch, R.A. USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: Preliminary results. Eur Radiol 2004, 14: 937-44.
37. Enochs, W.S., Harsh, G., Hochberg, F. and Weissleder, R. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 1999, 9: 228-32.
38. Harris, J.M. and Chess, R.B. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003, 2: 214-21.
39. Kommareddy, S., Tiwari, S.B. and Amiji, M.M. Long-circulating polymeric nanovectors for tumor-selective gene delivery. Technol Cancer Res Treat 2005, 4: 615-25.
40. Saksena, M.A., Saokar, A. and Harisinghani, M.G. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging. Eur J Radiol 2006, 58: 367-74.
41. Bischof Delaloye, A. Radioimmunoimaging and radioimmunotherapy: Will these be routine procedures? Semin Nucl Med 2000, 30: 186-94.
42. Press, O.W. and Rasey, J. Principles of radioimmunotherapy for hematologists and oncologists. Semin Oncol 2000, 27(6 Suppl. 12): 62-73.
43. Shinkai, M., Le, B., Honda, H. et al. Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes. Jpn J Cancer Res 2001, 92: 1138-45.
44. Huh, Y.M., Jun, Y.W., Song, H.T. et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc 2005, 127: 12387-91.
45. Moghimi, S.M., Hunter, A.C. and Murray, J.C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev 2001, 53: 283-318.
46. Sudimack, J. and Lee, R.J. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000, 30, 41: 147-62.
47. Sun, C., Sze, R. and Zhang, M. Folic acid-PEG conjugated superparamagnetic nano-particles for targeted cellular uptake and detection by MRI. J Biomed Mater Res A 2006, 78: 550-7.
48. Lucignani, G. Pivotal role of nanotechnologies and biotechnologies for molecular imaging and therapy. Eur J Nucl Med Mol Imaging 2006, 33: 849-51.
49. Ascencio, J.A., Rincon, A.C. and Canizal, G. Synthesis and theoretical analysis of samarium nanoparticles: Perspectives in nuclear medicine. J Phys Chern B Condens Matter Mater Surf Interfaces Biophys 2005, 109: 8806-12.
50. Vavuranakis, M., Kakadiaris, I.A., O'Malley, S.M. et al. Images in cardiovascular medicine. Detection of luminal-intimal border and coronary wall enhancement in intravascular ultrasound imaging after injection of microbubbles and simultaneous sonication with transthoracic echocardiography. Circulation 2005, 112: 1-2.
51. Waxman, S., Ishibashi, F. and Muller, J.E. Detection and treatment of vulnerable plaques and vulnerable patients: Novel approaches to prevention of coronary events. Circulation 2006, 114: 2390-411.
52. Sidhu, P.S., Shaw, A.S., Ellis, S.M., Karani, J.B. and Ryan, S.M. Microbubble ultrasound contrast in the assessment of hepatic artery patency following liver transplantation: role in reducing frequency of hepatic artery arteriography. Eur Radiol 2004, 14: 21-30.
53. Wheatley, M.A., Forsberg, F., Dube, N., Patel, M. and Oeffinger, B.E. Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging. Ultrasound Med Biol 2006, 32: 83-93.
54. Liu, J., Levine, A.L., Mattoon, J.S., Yamaguchi, M., Lee, R.J., Pan, X. and Rosol, T.J. Nanoparticles as image enhancing agents for ultrasonography. Phys Med Biol 2006, 51: 2179-89.
55. Davda, J. and Labhasetwar, V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 2002, 21, 233: 51-9.
56. Kato, T., Yashiro, T., Murata, Y. et al. Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries. Cell Tissue Res 2003, 311: 47-51.
57. Florence, A.T. and Hussain, N. Transcytosis of nanoparticle and dendrimer delivery systems: Evolving vistas. Adv Drug Deliv Rev 2001, 50(Suppl. 1): S69-89.
58. Hoet, P.H. and Nemery, B. Stimulation of phagocytosis by ultrafine particles. Toxicol Appl Pharmacol 2001, 176: 203.
59. Lanone, S. and Boczkowski, J. Biomedical applications and potential health risks of nanomaterials: Molecular mechanisms. Curr Mol Med 2006, 6: 651-63.
60. Avazzana-Calvo, M., Thrasher, A. and Mavilio, F. The future of gene therapy. Nature 2004, 26, 427: 779-81.
61. Moghimi, S.M., Hunter, A.C. and Murray, J.C. Nanomedicine: Current status and future prospects. FASEB J 2005, 19: 311-30.
62. Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N.M., Alving, C.R. and Muggia, F.M. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): Possible role in hypersensitivity reactions. Ann Oncol 2003, 14: 1430-7
63. Hoet, P.H., Nemmar, A. and Nemery, B. Health impact of nanomaterials? Nat Biotechnol 2004, 22: 19.
64. Wu, Z., Asokan, A. and Samulski, R.J. Adeno-associated virus serotypes: Vector toolkit for human gene therapy. Mol Ther 2006, 14: 316-27.
65. Thorsen, F., Afione, S., Huszthy, P.C. et al. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma. J Gene Med 2006, 8: 1131-40.
66. Hoffmann, D. and Wildner, O. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli. BMC Biotechnol 2006, 6: 36.
67. Cavaliere, R., Ciocatto, B.C., Giovanella, B.C. et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer 1967, 20: 1351-81.
68. Ito, A., Honda, H. and Kobayashi, T. Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: A novel concept of "heat-controlled necrosis" with heat shock protein expression. Cancer Immunol Immunother 2006, 55: 320-8.
69. Yanase, M., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J. and Kobayashi, T. Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn J Cancer Res 1998, 89: 775-82.
70. Awai, N., Ito, A., Nakahara, Y. et al. Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats. Prostate 2005, 64: 373-81.
71. Kawai, N., Ito, A., Nakahara, Y. et al. Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core. Prostate 2006, 66: 718-27.
72. Gradishar, W.J. Albumin-bound paclitaxel: A next-generation taxane. Expert Opin Pharmacother 2006, 7: 1041-53.